bio & engineering
high dimensional space
Joined November 2011
- Tweets6.1K
- Following2.1K
- Followers1.4K
- Likes19K
The @StammBio 's High Throughput Bioprocessor (HTB) is alive 🚀🧬: the live demo at BioUSA 2026 shows how the HTB automates a bubble-free laminar flow continuous biomanufacturing operation. Take a look at stamm.bio/
At Booth 5735, Juan Martín Cabaleiro, PhD (our CTO), is running the HTB live, walking visitors through a full demo from cold start to continuous perfusion.
View the whole demo here: linkedin.com/posts/stammbio_…
#BIO2026
martin palazzo retweeted
We're bringing something new to BIO International Convention 2026.
Juan Martin Cabaleiro, Subhadeep Das, Faith Wallace-Gadsden, and Jean-Christophe Quillet will be there representing Stämm and running the first public demos of the HTB: our High-Throughput Bioprocessor live.
martin palazzo retweeted
Recently, I was teaching the Law of Large Numbers and diversification, so I decided to share this illustration here.
As you average more and more independent, identically noisy copies of an image, the noise cancels out and the original emerges.
Code in the comments.
martin palazzo retweeted
Hoy es un día importante.
Stämm, una startup BIO argentina de deep tech, acaba de traer un pedazo de futuro al presente.
Hoy se festeja. 🇦🇷🌱
Amazing news: The @StammBio 's High Throughput Bioprocessor is alive 🧬🧬🧬 .
The automated platform based on continuous laminar flow microfluidics changes the game in scaling bio-manufacturing. Take a look 👇
martin palazzo retweeted
my (first!) article, “From the virtual community to ‘Trust and Safety’: eBay (1995–2007) and the rise of platform governance” is out on Big Data & Society! it is a history of content moderation at eBay, where they coined the term Trust and Safety 🌐 link below
martin palazzo retweeted
can confirm these are the vibes
if you’re questioning whether staying in academia, quant, big tech, or a big lab is how you want to spend the singularity, hit me up
martin palazzo retweeted
For decades in the biopharmaceutical industry, bigger was better: massive tanks, sprawling facilities, global blockbusters. But rising biosimilar competition and demand for specialized therapies are forcing a shift. The old batch paradigm is giving way to a new way.
martin palazzo retweeted
Never been a better time to pivot into biology.
The problems are very far from solved. Engineering skills will be extremely important in continuing to push the frontier forward. It's hard, but wildly worthwhile.
Leave B2B SaaS to agents :)
as a software engineer, i feel a real loss of identity right now.
for a long time i defined myself in part by the act of writing code. the pride in a hard-earned solution was part of who i was. now i watch AI accomplish in seconds what took me hours. i find myself caught between relief and mourning, awe and anxiety. the craft that shaped me is suddenly eclipsed by a machine. who am i now?